Recently Approved: iPro2 Continuous Glucose Monitoring System - P150029

iPro2 Continuous Glucose Monitoring System - P150029

Recently, FDA approved the iPro2, a professional-use continuous glucose monitoring (CGM) System that measures glucose levels in fluid under the skin for up to six days. Glucose values are stored by the iPro2 recorder for use by a health care provider to monitor a patient's glucose management; the values cannot be viewed in real time by the user.

Helene Clayton-Jeter, O.D.
Office of Health and Constituent Affairs
Food and Drug Administration

For more information about the Cardiovascular & Endocrine Liaison Program visit the FDA Patient Network